We enjoyed speaking to Carl Regillo (Wills Eye Hospital, Philadelphia, PA, USA) about incidence and prognosis of geographic atrophy, and advances in understanding of genetics and pathophysiology of dry AMD.
Questions
- Could you give us a brief overview of geographic atrophy, its incidence and prognosis? (00:17)
- Why have we failed to achieve the same breakthroughs in the treatment of dry age-related macular degeneration (AMD) as that of wet AMD? (02:11)
- What advances have been made in our understanding of the genetics and pathophysiology of dry AMD? (03:28)
Speaker Disclosure: Carl Regillo has no financial or non-financial relationships or activities to declare in relation to this interview.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Lisa Glass.
Filmed in coverage of Hawaiian Eye and Retina 2021.
